2009-11-30 01:24:28 -
PennyOmega.com is pleased to announce its X-Tra Hot Watch List!
***FREE Stock Alerts*** From CRWENEWSWIRE's PennyOmega.com
Click on the link Below:
www.crwenewswire.com/c/pennyomega
__
PWRM, Power3 Medical Products, Inc., PWRM.OB
PWRM is a leading bio-medical company engaged in the commercialization of neurodegenerative disease and cancer biomarkers, pathways, and mechanisms of diseases through the development of several blood tests designed for early detection, monitoring and targeting of diseases like Alzheimer’s, Parkinson’s and breast cancer.
Diagnostic tests are targeted toward markets with critical unmet needs in areas including neurodegenerative disease (NuroPro) and breast cancer (BC-SeraPro). PWRM expects to complete phase II clinical validation trials of its blood serum diagnostics for Alzheimer’s disease (NuroPro-AD), and Parkinson’s disease (NuroPro-PD) in 2009 and for breast
cancer in 2010, followed by filings with the FDA.
PWRM has had impressive short-term moves during the last two weeks! So, make sure to research PWRM as soon as possible!
Recently, PWRM’s advanced blood screening tests for early detection, monitoring and targeting of diseases like Alzheimer’s, Parkinson’s and breast cancer were exposed to over 50,000 scientists worldwide during the BTI Life Sciences 2nd Annual Congress and Expo of Molecular Diagnostics in Beijing.
** There are no other current blood based test available for early stage diagnosis or monitoring of therapies in development, plus with that kind of exposure, we believe investors will love PWRM at this level ($0.19). PWRM could be ready to breakout HUGE in no time!
__
PGCX, PanGenex Corporation, PGCX.PK
PGCX pursues business opportunities in the $70 billion dollar nutraceutical and dietary supplement industry. With a focus specifically on the cardiovascular health segment, PGCX develops and markets sector leading, patented or patent pending, condition specific nutraceuticals and topical over-the-counter (OTC) drugs and personal care products.
Clinical trial involving a protocol to test PGCX’s product Calci-CLEAR, a two part system designed to cleanse and remove calcium deposits from soft tissues such as veins and arteries (an important and pervasive condition affecting hundreds of millions of people worldwide), showed promising pre-clinical results.
PGCX anticipated the release of its long form television program, demonstrating the benefits of Calci-CLEAR™, its patent pending dietary supplement that addresses soft tissue calcification, pursuant to its partnership with Incredible Discoveries® in early 2010.
This program will allow PGCX and its physician partners to reach a broad and diverse audience, an audience where an estimated 1 of every 5 adults has complications associated with soft tissue calcification, Opening the Door to a Multi-billion Dollar Nutraceutical and Dietary Supplement Industry.
__
TAXS, TaxMasters, Inc., TAXS.OB
TAXS is the IRS tax relief company.
Federal tax debt is serious and the IRS is a terrifying opponent for anyone with tax problems. TAXS deals with the IRS every day and they are familiar with the laws they must follow when collecting revenue. TAXS offers tax relief services specifically designed to reduce and eliminate federal tax debt.
Last week, TAXS Filed Form 10-Q. To consider:
- Revenues for the nine months ended September 30, 2009 increased by approximately $12,584,782, or 87.5%, from approximately $14,385,985 for the nine months end September 30, 2008 to approximately $26,970,767 for the same period in 2009.
- Revenues for the three months ended September 30, 2009 increased by $236,759, or 3.0%, from $7,975,655 for the three months end September 30, 2008 to $8,212,414 for the same period in 2009.
__
About PennyOmega.com
PennyOmega.com is a stock watch website, a CRWENewsWire.com Division that provides free daily alerts on stocks. PennyOmega.com's alerts are daily e-mail on stocks that are hot in the market. These include stocks with huge volume, penny stocks, stocks with technical indicators and much more. PennyOmega.com also tracks small cap stocks that are on the brink of moving upwards. PennyOmega.com also features companies on its website with research report, analysis, and newsletters.
PennyOmega.com is an independent electronic publication that provides information on selected publicly traded companies. PennyOmega.com is not a registered investment advisor or broker-dealer. THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! Please do your own Due Diligence before investing in any of the stocks mentioned above. The disclaimer is to be read and fully understood before using our sites, stock alerts, watch list or joining our email list. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) has received twenty four thousand dollars from Tax Masters Inc. (TAXS.OB) for 30 days of advertisement services. Crown Equity Holdings, Inc. (CRWE.OB) has previously received five hundred thousand shares compensation for 30 days of advertisement services and has received an additional 1,000,000 shares 144 restricted stocks for 6 months of advertisement and diseminate news and $15,000 dollars for IR services for Power 3 Medical Products Inc. (PWRM.OB). Full disclaimer can be read at www.PennyOmega.com.
We encourage investors to join the FREE e-mail alerts by visiting:
www.crwenewswire.com/c/pennyomega
About CRWENewswire.com
CRWENewswire.com is an independent electronic informative online financial news publication company dedicated in providing company associates, business and financial professionals with economic and investment information, as well as stock highlights. CRWENewswire.com is a division of Crown Equity Holdings, Inc.
***FREE STOCK ALERTS**
Sign up to receive FREE stock alerts from CRWENewswire's PennyOmega.com at
www.crwenewswire.com/c/pennyomega
Forward Looking Statement
This press release contains forward-looking statements within the meaning of section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. With the exception of historical information contained herein, the matters discussed in this press release involve risk and uncertainties. Actual results could differ materially from those expressed in any forward-looking statement.
Contact PennyOmega.com
arnu@pennyomega.com 
